$8.51
-0.13-1.50%
At close: -
$8.50
-0.01000-0.12%
After Hours: 4:54 PM EDT
Novavax reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novavax using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.76 | $-0.83 | 8.43 % |
Jun 2024 | 2024-08-08 | $0.99 | $1.36 | -27.2 % |
Mar 2024 | 2024-05-10 | $-1.05 | $-1.06 | 0.94 % |
Dec 2023 | 2024-02-28 | $-1.47 | $-0.45 | -226.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $84.51M | $65.77M | 28.5 % |
Jun 2024 | 2024-08-08 | $415.48M | $414.82M | 0.16 % |
Mar 2024 | 2024-05-10 | $93.86M | $101.16M | -7.22 % |
Dec 2023 | 2024-02-28 | $291.34M | $321.65M | -9.42 % |
Novavax (NVAX) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.76, which beat the estimate of $-0.83.
The Actual Revenue was $84.5M, which beat the estimate of $65.8M.
Browse earnings estimates, EPS, and revenue on all stocks.